Defining ‘Satisfactory Response’ to Therapy in Abdominal Tuberculosis: A Work in Progress

Author(s): Vishal Sharma*, Harjeet Singh, Harshal S. Mandavdhare

Journal Name: Infectious Disorders - Drug Targets
(Formerly Current Drug Targets - Infectious Disorders)

Volume 20 , Issue 2 , 2020

Become EABM
Become Reviewer

Abstract:

Abdominal tuberculosis is difficult to diagnose due to low sensitivity of microbiological tests and the low histological yield. Satisfactory response to therapy has long been used a criteria for the diagnosis of abdominal tuberculosis. However, the appropriate definitions of response to therapy in abdominal tuberculosis have remained unclear. Recent evidence suggests that mucosal healing of ulcers at the end of therapy or at two months (early mucosal response) is a helpful criteria of response to therapy. This also helps in exclusion of multidrug resistant tuberculosis and alternative diagnosis like Crohn’s disease. Further limited literature suggests the use of some biomarkers like C-reactive protein in the follow-up of patients with peritoneal or intestinal tuberculosis.

Keywords: Peritoneal tuberculosis, ulcer healing, cocoon, intestinal tuberculosis, strictures, pancreatic tuberculosis, hepatic tuberculosis.

[1]
Sharma,., V;; Debi,, U Mandavdhare, HS; Prasad, KK Abdominal Tuberculosis and Other Mycobacterial Infections. In: Encyclopedia of Gastroenterology, 2nd Edition;;
[http://dx.doi.org/10.1016/B978-0-12-801238-3.65963-9]
[2]
Debi, U.; Ravisankar, V.; Prasad, K.K.; Sinha, S.K.; Sharma, A.K. Abdominal tuberculosis of the gastrointestinal tract: revisited. World J. Gastroenterol., 2014, 20(40), 14831-14840.
[http://dx.doi.org/10.3748/wjg.v20.i40.14831] [PMID: 25356043]
[3]
Gaikwad, U.N.; Gaikwad, N.R. Modalities to monitor the treatment response in tuberculosis. Indian J. Tuberc., 2018, 65(2), 109-117.
[http://dx.doi.org/10.1016/j.ijtb.2017.12.014] [PMID: 29579423]
[4]
Cherian, J.J.; Lobo, I.; Sukhlecha, A.; Chawan, U.; Kshirsagar, N.A.; Nair, B.L.; Sawardekar, L. Treatment outcome of extrapulmonary tuberculosis under Revised National Tuberculosis Control Programme. Indian J. Tuberc., 2017, 64(2), 104-108.
[http://dx.doi.org/10.1016/j.ijtb.2016.11.028] [PMID: 28410692]
[5]
Mandavdhare, H.S.; Singh, H.; Sharma, V. Recent advances in the diagnosis and management of abdominal tuberculosis. EMJ Gastroenterol., 2017, 6(1), 52-60.
[6]
Logan, V.S. Anorectal tuberculosis. Proc. R. Soc. Med., 1969, 62(12), 1227-1230.
[http://dx.doi.org/10.1177/003591576906201214] [PMID: 5363105]
[7]
Sharma, V.; Mandavdhare, H.S.; Lamoria, S.; Singh, H.; Kumar, A. Serial C-reactive protein measurements in patients treated for suspected abdominal tuberculosis. Dig. Liver Dis., 2018, 50(6), 559-562.
[http://dx.doi.org/10.1016/j.dld.2017.12.008] [PMID: 29301734]
[8]
Makharia, G.K.; Srivastava, S.; Das, P.; Goswami, P.; Singh, U.; Tripathi, M.; Deo, V.; Aggarwal, A.; Tiwari, R.P.; Sreenivas, V.; Gupta, S.D. Clinical, endoscopic, and histological differentiations between Crohn’s disease and intestinal tuberculosis. Am. J. Gastroenterol., 2010, 105(3), 642-651.
[http://dx.doi.org/10.1038/ajg.2009.585] [PMID: 20087333]
[9]
Pratap Mouli, V.; Munot, K.; Ananthakrishnan, A.; Kedia, S.; Addagalla, S.; Garg, S.K.; Benjamin, J.; Singla, V.; Dhingra, R.; Tiwari, V.; Bopanna, S.; Hutfless, S.; Makharia, G.; Ahuja, V. Endoscopic and clinical responses to anti-tubercular therapy can differentiate intestinal tuberculosis from Crohn’s disease. Aliment. Pharmacol. Ther., 2017, 45(1), 27-36.
[http://dx.doi.org/10.1111/apt.13840] [PMID: 27813111]
[10]
Sharma, V.; Mandavdhare, H.S.; Dutta, U. Letter: mucosal response in discriminating intestinal tuberculosis from Crohn’s disease-when to look for it? Aliment. Pharmacol. Ther., 2018, 47(6), 859-860.
[http://dx.doi.org/10.1111/apt.14495] [PMID: 29446132]
[11]
Larsson, G.; Shenoy, K.T.; Ramasubramanian, R.; Thayumanavan, L.; Balakumaran, L.K.; Bjune, G.A.; Moum, B.A. Faecal calprotectin levels differentiate intestinal from pulmonary tuberculosis: An observational study from Southern India. United European Gastroenterol. J., 2014, 2(5), 397-405.
[http://dx.doi.org/10.1177/2050640614546947] [PMID: 25360318]
[12]
Puri, A.S.; Sachdeva, S.; Mittal, V.V.; Gupta, N.; Banka, A.; Sakhuja, P.; Puri, S.K. Endoscopic diagnosis, management and outcome of gastroduodenal tuberculosis. Indian J. Gastroenterol., 2012, 31(3), 125-129.
[http://dx.doi.org/10.1007/s12664-012-0203-3] [PMID: 22711366]
[13]
Udgirkar, S.; Surude, R.; Zanwar, V.; Chandnani, S.; Contractor, Q.; Rathi, P. Gastroduodenal tuberculosis: A case series and review of literature. Clin. Med. Insights Gastroenterol., , 2018. 11, 1179552218790566
[http://dx.doi.org/10.1177/1179552218790566] [PMID: 30083063]
[14]
Sharma, V.; Rana, S.S.; Kumar, A.; Bhasin, D.K. Pancreatic tuberculosis. J. Gastroenterol. Hepatol., 2016, 31(2), 310-318.
[http://dx.doi.org/10.1111/jgh.13174] [PMID: 26414325]
[15]
Kim, J.B.; Lee, S.S.; Kim, S.H.; Byun, J.H.; Park, D.H.; Lee, T.Y.; Lee, B.U.; Jeong, S.U.; Seo, D.W.; Lee, S.K.; Kim, M.H. Peripancreatic tuberculous lymphadenopathy masquerading as pancreatic malignancy: a single-center experience. J. Gastroenterol. Hepatol., 2014, 29(2), 409-416.
[http://dx.doi.org/10.1111/jgh.12410] [PMID: 24303923]
[16]
Santhosh, S.; Bhattacharya, A.; Rana, S.S. BhasinDk, Srinivasan R, Mittal BR. Pancreatic tuberculosis: Evalutaion of therapeutic response using F-18 flouro-2-deoxy-D-glucose positron emission tomograpgy/ computed tomography. Indian J. Nucl. Med., 2014, 29(4), 257-259.
[http://dx.doi.org/10.4103/0972-3919.142635] [PMID: 25400368]
[17]
Amarapurkar, D.N.; Patel, N.D.; Amarapurkar, A.D. Hepatobiliary tuberculosis in western India. Indian J. Pathol. Microbiol., 2008, 51(2), 175-181.
[http://dx.doi.org/10.4103/0377-4929.41644] [PMID: 18603675]
[18]
Hickey, A.J.; Gounder, L.; Moosa, M.Y.; Drain, P.K. A systematic review of hepatic tuberculosis with considerations in human immunodeficiency virus co-infection. BMC Infect. Dis., 2015, 15, 209.
[http://dx.doi.org/10.1186/s12879-015-0944-6] [PMID: 25943103]
[19]
Shejul, Y.; Chhajed, P.N.; Basu, S. 18F-FDG PET and PET/CT in diagnosis and treatment monitoring of pyrexia of unknown origin due to tuberculosis with prominent hepatosplenic involvement. J. Nucl. Med. Technol., 2014, 42(3), 235-237.
[http://dx.doi.org/10.2967/jnmt.113.132985] [PMID: 24948823]
[20]
Sharma, V.; Mandavdhare, H.S.; Rana, S.S.; Singh, H.; Kumar, A.; Gupta, R. Role of conservative management in tubercular abdominal cocoon: a case series. Infection, 2017, 45(5), 601-606.
[http://dx.doi.org/10.1007/s15010-017-1012-5] [PMID: 28341896]
[21]
Gorsi, U.; Gupta, P.; Mandavdhare, H.S.; Singh, H.; Dutta, U.; Sharma, V. The use of computed tomography in the diagnosis of abdominal cocoon. Clin. Imaging, 2018, 50, 171-174.
[http://dx.doi.org/10.1016/j.clinimag.2018.03.014] [PMID: 29602067]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 20
ISSUE: 2
Year: 2020
Page: [111 - 114]
Pages: 4
DOI: 10.2174/1871526518666181022111323
Price: $65

Article Metrics

PDF: 22
HTML: 2